Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, September 1, 2010
Tue, August 31, 2010
Mon, August 30, 2010 ASFN, JLIC, BHRT, AXMIF Have Been Added To Naked Short Lists This Week
August 30, 2010 /M2 PRESSWIRE/ BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold lists. Atlantic Southern Financial Group (NASDAQ: ASFN), Jesup and Lamont (OTC: JLIC), BioHeart (OTCBB: BHRT) and AXMIN (OTC: AXMIF). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
Atlantic Southern Financial Group, Inc. (NASDAQ: ASFN) operates as the holding company for Atlantic Southern Bank that offers banking and financial products and services to individuals, small to medium-sized business, and professional concerns in the United States. The company provides a range of deposit products, including checking accounts, savings accounts, money market accounts, and certificates of deposit. Its loans portfolio comprises construction and land development, farmland, residential first liens, residential JR. liens, multi-family residential, nonfarm, and nonresidential loans; and home equity lines of credit. The company also offers commercial, industrial, agricultural production, and consumer installment loans, as well as credit cards and other revolving credit. In addition, it provides Internet banking, direct deposit, safe deposit boxes, the United States savings bonds, and automatic account transfer services. The company offers its products and services through its nine banking locations in the central Georgia markets of Macon, Warner Robins, Roberta, Lizella, Bonaire, and Byron; five in the coastal Georgia markets of Savannah, Darien, Rincon, and Brunswick; one location in the south Georgia market of Valdosta; and one banking location in Jacksonville, Florida. Atlantic Southern Financial Group, Inc. was founded in 2001 and is headquartered in Macon, Georgia. There is a failure to deliver in shares of ASFN.
Jesup & Lamont, Inc. (OTC: JLIC), through its subsidiaries, provides securities brokerage, investment banking, market making research, investment advisory, asset management services, and order execution services to retail and institutional customers primarily in the United States, Europe, and Asia. It offers brokerage services, including ancillary services, such as market data and financial information, portfolio tracking and records management, account security, and cash management services directly to retail customers, including individuals, and small to mid-sized institutions, such as banks, credit unions, hedge funds, money managers, mutual funds, and pension funds. The company also provides municipal bond and corporate/high yield bond trading, and certificate of deposit underwriting services; and market making and order execution services, which include filling orders received from independent broker dealers to buy or sell domestic or foreign securities for affiliated and unaffiliated broker dealers and institutions. In addition, it offers investment advisory services, including investment portfolio planning, recommendations and separate account manager and mutual fund research and due diligence, portfolio performance review and reallocation, and wrap accounts for registered investment advisors. The company was formerly known as Empire Financial Holding Company and changed its name to Jesup & Lamont, Inc. in January 2008. Jesup & Lamont was founded in 2000 and is headquartered in New York, New York. On July 30, 2010, Jesup & Lamont, Inc. filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the Southern District of New York. There is a failure to deliver in shares of JLIC.
Bioheart, Inc. (OTCBB: BHRT) focuses on the discovery, development, and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage and peripheral vascular disease in the United States and internationally. The companya�s lead product candidate include MyoCell, a clinical muscle-derived cell therapy designed to populate regions of scar tissue in a patienta�s heart with new living cells for improving cardiac function in chronic heart failure patients. It also offers Bioheart 3370 Heart Failure Monitor for heart failure patients. The companya�s products under development include Bioheart Acute Cell Therapy, an autologous adipose cell treatment for acute heart damage; TGI 1200 Adipose Tissue Processing System, an automated device for the rapid processing of patient derived fat tissue; and MyoCell SDF-1, an autologous cell therapy for the treatment of severe chronic damage to the heart and cells modified to express angiogenic factors. Its product candidates also include MyoCath, a disposable endoventricular catheter used for the delivery of biologic solutions to the myocardium; and MyoCath II, a second generation disposable endoventricular catheter to provide multidirectional cell injection for the delivery of biologic solutions to the myocardium. The company was founded in 1999 and is headquartered in Sunrise, Florida. There is a failure to deliver in shares of BHRT.
AXMIN Inc. (OTC: AXMIF), a development stage company, engages in the exploration and development of mineral properties, primarily gold properties in central and west Africa. It has interests in the Bambari, Bakala, Bogoin II and Pouloubou exploration permits, including the Passendro Gold Project in the Central African Republic; Kofi North, Netekoto-Kenieti, Walia West, Walia, Kenieti-Dianisse, and Satifara permits in Mali; the Nimini Hills, Makong, and Matotaka exploration permits in Sierra Leone; and the Sonkounkou, Sabodala NW, and Heremakono exploration permits in Senegal. The company was formerly known as Asquith Resources Inc. AXMIN Inc. is headquartered in Toronto, Canada. There is a failure to deliver in shares of AXMIF.
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,750,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
Contact: Thomas Ronk / CEO www.BUYINS.net (800) 715-9999 tom@buyins.net
- WOPRAI
- support@woprai.com